Literature DB >> 32199105

Deciphering the power of isolation in controlling COVID-19 outbreaks.

Yan Niu1, Fujie Xu2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32199105      PMCID: PMC7269718          DOI: 10.1016/S2214-109X(20)30085-1

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


× No keyword cloud information.
Isolation of cases and contacts has long been a strategy in the fight against infectious diseases; however, its effectiveness has varied. The modelling study by Joel Hellewell and colleagues qualitatively explored the parameters that determine whether isolation of cases and contacts can successfully contain COVID-19 outbreaks after importation of travel-related cases and initial transmissions. Initial outbreak sizes were among the key determinants for the success of isolation. 2 months ago, the world knew almost nothing about COVID-19, and Wuhan—the epicentre of the outbreak—did not have the luxury of early detection and response. Challenged by the reality that earlier opportunities had been missed, China launched a costly public health response in Wuhan, which involved many tactics besides isolation of cases and contacts, including lockdown of the city and mass quarantine, social distancing mandates, school closures, and intense case finding and contact tracing by the medical and public health professionals who were mobilised across the country to come to Wuhan.2, 3, 4 The approach in Wuhan and the nearby cities in Hubei Province took exceptional measures in response to the outbreak, because there was evidence of high-level community transmission and widespread nosocomial infections. As of Feb 11, 2020, 3019 COVID-19 cases among health workers had been reported, with at least five deaths.5, 6 In many regions outside of China, decision makers and the medical community still have the opportunity of early detection and response. The Article by Hellewell and colleagues gives us a clearer sense of how quickly the window for early response is closing: when the number of initial cases increases to 40, the probability of failure to control is high, at 80% even with 80% of contacts traced and isolated. Based on the early experience in Wuhan, the number of COVID-19 cases could increase from 20 to 40 cases within 3 days (from Jan 6–8, 2020), and outbreak sizes doubled in every 7·4 days on average, highlighting the urgency of early detection and rapid response. In Hellewell and colleagues' model, transmission before symptoms, even when the percentage is moderate, at 15–30%, had a marked effect on probability to control. Unlike the severe acute respiratory syndrome virus, where almost all onward transmissions occur after symptom onset, we now know that transmission of COVID-19 virus can occur before symptom onset. In the fifth version of Chinese guidelines governing contact tracing, it defined close contacts as “those who have been in close contact since 2 days before the onset of symptoms in suspected and confirmed cases, or 2 days prior to an asymptomatic confirmed case,” which reflects our current understanding that secondary transmission of COVID-19 virus is possible at least 2 days before symptom onset. However, the efficiency of transmission remains uncertain, and seroprevalence studies among different contacts will be important. Transmission by people with no or mild symptoms can dampen the power of the isolation strategy because of reduced likelihood of isolating all cases and tracing all contacts. The identification and testing of potential cases need to be as extensive as is permitted by health care and diagnostic testing capacity—including the identification, testing, and isolation of suspected cases with no or mild disease (eg, influenza-like illness). Another major challenge to the completeness in case isolation is that nucleic acid testing—the main tool for case identification—has a variable rate of false-negative results; so even symptomatic cases could be set free, and thus weakening the feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Aiming to improve the completeness of isolation to curb all transmissions, Hubei province revised the case definition between Feb 5 and 18, 2020, and added clinically diagnosed cases, which eliminated the requirement for a positive nucleic acid test. The development of better tests is a research priority internationally. With more research and high-tech groups joining the fight, we might also see advances in contact tracing. In this fight against COVID-19, control measures such as isolation and contact tracing might indeed gain more power, thanks to modern technology. This online publication has been corrected. The corrected version first appeared at thelancet.com/lancetgh on March 26, 2020
  6 in total

1.  [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China].

Authors:  W Chen; Q Wang; Y Q Li; H L Yu; Y Y Xia; M L Zhang; Y Qin; T Zhang; Z B Peng; R C Zhang; X K Yang; W W Yin; Z J An; D Wu; Z D Yin; S Li; Q L Chen; L Z Feng; Z J Li; Z J Feng
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2020-03-06

2.  [Consideration on the strategies during epidemic stage changing from emergency response to continuous prevention and control].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-03-10

3.  Modeling and public health emergency responses: lessons from SARS.

Authors:  John W Glasser; Nathaniel Hupert; Mary M McCauley; Richard Hatchett
Journal:  Epidemics       Date:  2011-01-28       Impact factor: 4.396

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  6 in total
  25 in total

1.  Artificial intelligence against the first wave of COVID-19: evidence from China.

Authors:  Ting Wang; Yi Zhang; Chun Liu; Zhongliang Zhou
Journal:  BMC Health Serv Res       Date:  2022-06-10       Impact factor: 2.908

2.  Current status and influential factors for family health management during quarantine: A latent category analysis.

Authors:  Guangming Li; Mengying Li; Shuzhen Peng; Ying Wang; Li Ran; Xuyu Chen; Ling Zhang; Sirong Zhu; Qi Chen; Wenjing Wang; Yang Xu; Yubin Zhang; Xiaodong Tan
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.752

3.  Internet Hospitals Help Prevent and Control the Epidemic of COVID-19 in China: Multicenter User Profiling Study.

Authors:  Kai Gong; Zhong Xu; Zhefeng Cai; Yuxiu Chen; Zhanxiang Wang
Journal:  J Med Internet Res       Date:  2020-04-14       Impact factor: 5.428

Review 4.  A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments.

Authors:  Pedro Aa Monteleone; Mayra Nakano; Victor Lazar; Alecsandra P Gomes; Hamilton de; Tatiana Cs Bonetti
Journal:  JBRA Assist Reprod       Date:  2020-05-01

5.  The potential effects of widespread community transmission of SARS-CoV-2 infection in the World Health Organization African Region: a predictive model.

Authors:  Joseph Waogodo Cabore; Humphrey Cyprian Karamagi; Hillary Kipruto; James Avoka Asamani; Benson Droti; Aminata Binetou Wahebine Seydi; Regina Titi-Ofei; Benido Impouma; Michel Yao; Zabulon Yoti; Felicitas Zawaira; Prosper Tumusiime; Ambrose Talisuna; Francis Chisaka Kasolo; Matshidiso R Moeti
Journal:  BMJ Glob Health       Date:  2020-05

Review 6.  Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Authors:  Andrea Murru; Mirko Manchia; Tomas Hajek; René E Nielsen; Janusz K Rybakowski; Gabriele Sani; Thomas G Schulze; Leonardo Tondo; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2020-05-20

7.  Eating disorders during the COVID-19 pandemic and quarantine: an overview of risks and recommendations for treatment and early intervention.

Authors:  Marita Cooper; Erin E Reilly; Jaclyn A Siegel; Kathryn Coniglio; Shiri Sadeh-Sharvit; Emily M Pisetsky; Lisa M Anderson
Journal:  Eat Disord       Date:  2020-07-09       Impact factor: 3.222

8.  Data-driven test strategy for COVID-19 using machine learning: A study in Lahore, Pakistan.

Authors:  Chuanli Huang; Min Wang; Warda Rafaqat; Salman Shabbir; Liping Lian; Jun Zhang; Siuming Lo; Weiguo Song
Journal:  Socioecon Plann Sci       Date:  2021-06-08       Impact factor: 4.923

9.  Preventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan's experience.

Authors:  Jing Liu; Bobin Mi; Liangcong Hu; Yuan Xiong; Hang Xue; Wu Zhou; Faqi Cao; Mengfei Liu; Lang Chen; Chenchen Yan; Hui Li; Guohui Liu
Journal:  Aging (Albany NY)       Date:  2020-05-07       Impact factor: 5.682

10.  Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic.

Authors:  Robert Dotzauer; Katharina Böhm; Maximilian Peter Brandt; Peter Sparwasser; Maximilian Haack; Sebastian Karl Frees; Mohamed Mostafa Kamal; René Mager; Wolfgang Jäger; Thomas Höfner; Igor Tsaur; Axel Haferkamp; Hendrik Borgmann
Journal:  World J Urol       Date:  2020-07-04       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.